Isabella Marchi
Modena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Characterization of Copy Number Variants in Hereditary Cancer Patients Through NGS Shows a Distinctive PALB2 Contribution to the Diagnostic Yield.
Journal: Human mutation
Published: May 13, 2025
Clinical outcome and proportion of hereditary cancer genes gPV in TNBC: the HEaRTBeat study.
Journal: NPJ breast cancer
Published: February 09, 2025
Constitutional Mosaicism: A Critical Issue in the Definition of BRCA-Inherited Cancer Risk.
Journal: JCO precision oncology
Published: September 08, 2022
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers.
Journal: Genes
Published: April 04, 2021
BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees.
Journal: Cancer biology & medicine
Published: March 12, 2021
The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study.
Journal: Diagnostics (Basel, Switzerland)
Published: February 26, 2021
BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy.
Journal: Cancers
Published: March 24, 2020
Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies.
Journal: Cancers
Published: December 29, 2018
Breast ultrasonography (BU) in the screening protocol for women at hereditary-familial risk of breast cancer: has the time come to rethink the role of BU according to different risk categories?
Journal: International journal of cancer
Published: February 04, 2018
BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotype.
Journal: Oncotarget
Published: October 24, 2016
Last Updated: 09/26/2026